Related Experiment Video
Updated: Jun 12, 2025

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
CXCL5 inhibition improves kidney function by protecting renal tubular epithelial cells in diabetic kidney disease
Ching Chen1, Liang-Yu Lin2, Yen-Wen Wu3
1Department and Institute of Pharmacology, National Yang Ming Chiao Tung University, Taipei, Taiwan; School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Abstract:
Inflammation is one of exacerbating factors of diabetic kidney disease (DKD). Upregulated CXCL5 is found in clinical and experimental diabetes studies. This study aimed to investigate the impact and mechanism of CXCL5 on DKD. DKD patients with different levels of urine albumin-to-creatinine ratio were enrolled. Leprdb/db mice and CXCL5-knockout diabetic mice were used as mouse models for DKD. Human renal tubular epithelial cells were used for in vitro experiments. Circulating CXCL5 were increased in DKD patients compared to the non-DKD subjects. CXCL5 inhibition through CXCL5-neutralizing antibodies or genetic knockout improved kidney function and ameliorated tubular injury and renal fibrosis. In high-glucose-stimulated tubular epithelial cells, administration of CXCL5-neutralizing antibodies or siRNA resulted in reduced phospho-JNK/c-JUN/p65 and the downstream inflammatory, fibrotic, and apoptotic protein expressions. Administration of CXCR2 and JNK inhibitors impeded the CXCL5-induced tubular epithelial cell damages. In conclusion, these findings indicated that anti-CXCL5 strategies may be potential treatments for DKD.
Insights
Targeting CXCL5, a key inflammatory factor, shows promise for treating diabetic kidney disease (DKD). Inhibiting CXCL5 improved kidney function and reduced damage in preclinical models, suggesting new therapeutic strategies for DKD.
Area of Science:
- Nephrology
- Immunology
- Molecular Biology
Background:
- Diabetic kidney disease (DKD) is a major complication of diabetes, exacerbated by inflammation.
- Elevated levels of CXCL5 are observed in both clinical and experimental diabetes, suggesting its role in DKD pathogenesis.
Purpose of the Study:
- To investigate the impact and underlying mechanisms of CXCL5 in the development and progression of diabetic kidney disease.
- To evaluate the therapeutic potential of inhibiting CXCL5 in DKD.
Main Methods:
- DKD patients and control subjects were enrolled, with urine albumin-to-creatinine ratio used for stratification.
- Leprdb/db mice and CXCL5-knockout diabetic mice served as DKD models.
- In vitro studies utilized human renal tubular epithelial cells stimulated with high glucose.
Main Results:
- Circulating CXCL5 levels were significantly higher in DKD patients compared to non-DKD subjects.
- CXCL5 inhibition (via antibodies or genetic knockout) improved kidney function, reduced tubular injury, and ameliorated renal fibrosis in mouse models.
- In vitro, CXCL5 inhibition decreased inflammatory, fibrotic, and apoptotic markers by suppressing JNK/c-JUN/p65 signaling pathways.
Conclusions:
- CXCL5 plays a significant role in the pathogenesis of diabetic kidney disease.
- Inhibiting CXCL5 demonstrates therapeutic potential for treating DKD by mitigating inflammation, fibrosis, and apoptosis.
- Anti-CXCL5 strategies represent a promising avenue for future DKD treatments.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
Renal Tubule and Collecting Duct
Proximal Convoluted Tubule (PCT):
The PCT is the initial segment of the renal tubule, extending from the Bowman's capsule that encloses the glomerulus. Its convoluted structure and microvilli-lined cells increase the surface area for reabsorption. The PCT reabsorbs glucose, amino acids, sodium, and water from the filtrate, ensuring essential...
Chronic Kidney Disease I: Introduction

